Recombinant cell line

Ended Purchase Order Awarded

Contract number
75D30121P11493
Awardee
Awarding agency
Obligated
$126,312

Award facts

Contract value 100% obligated
$126,311.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Alameda, CA 94502, USA
Legislative mandates
  • Other statutory authority

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order contract worth $126,311.80 to Fluxion Biosciences Inc., a manufacturer of automated patch clamp, cellular analysis, and liquid biopsy systems. The contract is for a "Recombinant Cell Line" with a completion date of September 30, 2021. Fluxion Biosciences Inc. has previously provided specialized biofluxion equipment, upgrades, cell lines, and microfluidic devices to agencies including the VA, CDC, and NIH through federal contracts and grants. This award does not have a set-aside designation.

Quick answers

Who was awarded contract 75D30121P11493?

75D30121P11493 was awarded to Fluxion Biosciences Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on June 15, 2021.

How much is contract 75D30121P11493 worth?

The government has obligated $126,312 on 75D30121P11493.

Was contract 75D30121P11493 competed?

The extent of competition for 75D30121P11493 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login